Humana Future Growth
Future criteria checks 1/6
Humana wird ein jährliches Wachstum der Erträge und Einnahmen um 13.7% bzw. 8.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich grow um 15.4% pro Jahr steigen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 21.7% betragen.
Key information
11.8%
Earnings growth rate
14.5%
EPS growth rate
Healthcare earnings growth | 12.3% |
Revenue growth rate | 5.7% |
Future return on equity | 17.6% |
Analyst coverage | Good |
Last updated | 02 Apr 2024 |
Recent future growth updates
Recent updates
Humana: Where To Buy This
Apr 02Humana: This Year's Drop Might Have Created A Buying Opportunity
Mar 19Humana: A Golden Buying Opportunity As Fears Potentially Peaked
Feb 03Humana: The $300 Level Could Get Taken Out In The Near Future
Jan 25Humana: My Oh My, Another Strong Buy
Jan 14Humana: Buy This Powerful Dividend Growth Stock In The New Year
Jan 02Does Humana (NYSE:HUM) Have A Healthy Balance Sheet?
Dec 14Humana: Failed Merger And Other Reasons To Buy
Dec 11Humana: Upgrade To Buy
Oct 06Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did
Sep 27We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease
Aug 25Humana: Mr. Market Got This One Right
Aug 03Humana: Recent Selloff Might Present A Buying Opportunity
Jul 13Humana: Rising Medical Costs Should Be Temporary
Jun 28Humana: Margin Expansion Supported By Growing Memberships
Jun 12Humana (NYSE:HUM) Seems To Use Debt Rather Sparingly
May 26Humana Inc. (NYSE:HUM) Shares Could Be 49% Below Their Intrinsic Value Estimate
Apr 13Humana Q4 2022 Earnings Preview
Jan 31Humana: Destined For A Long-Term Success
Jan 23Humana (NYSE:HUM) Could Easily Take On More Debt
Jan 13Humana receives $70.85B contract from Defense Health Agency
Dec 22Are Investors Undervaluing Humana Inc. (NYSE:HUM) By 34%?
Dec 20Humana: Top-Rated Medicare Advantage Insurer With Room To Grow
Nov 14Humana prices $1.23B debt offering
Nov 08Humana Q3 2022 Earnings Preview
Nov 01Humana expands partnership with Cohere Health on prior authorization services
Oct 24Humana announces major expansion of Florida Dental Network, benefits
Oct 17We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease
Oct 10Humana Inc.'s (NYSE:HUM) Intrinsic Value Is Potentially 92% Above Its Share Price
Sep 21Humana adds 9%, highest in over two years, after lifting guidance
Sep 15Humana: Time To Adopt A More Defensive Portfolio Strategy
Sep 04Humana declares $0.7875 dividend
Aug 18Humana to acquire Wisconsin managed care organization Inclusa
Aug 12Do Humana's (NYSE:HUM) Earnings Warrant Your Attention?
Aug 04Humana Non-GAAP EPS of $8.67 beats by $0.99, revenue of $23.72B beats by $280M
Jul 27Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 124,226 | 3,323 | 3,661 | 4,440 | 11 |
12/31/2025 | 117,141 | 2,805 | 3,247 | 3,885 | 16 |
12/31/2024 | 111,790 | 1,908 | 2,422 | 3,229 | 17 |
12/31/2023 | 106,374 | 2,489 | 2,977 | 3,981 | N/A |
9/30/2023 | 102,351 | 3,015 | 5,009 | 5,988 | N/A |
6/30/2023 | 98,727 | 3,378 | 12,156 | 13,189 | N/A |
3/31/2023 | 95,642 | 3,115 | 9,924 | 10,972 | N/A |
12/31/2022 | 92,870 | 2,806 | 3,450 | 4,587 | N/A |
9/30/2022 | 91,485 | 2,807 | 8,385 | 9,618 | N/A |
6/30/2022 | 90,512 | 3,143 | 2,729 | 4,000 | N/A |
3/31/2022 | 87,495 | 3,035 | 2,080 | 3,401 | N/A |
12/31/2021 | 83,064 | 2,933 | 920 | 2,262 | N/A |
9/30/2021 | 82,201 | 2,673 | 1,400 | 2,641 | N/A |
6/30/2021 | 80,450 | 2,482 | 456 | 1,621 | N/A |
3/31/2021 | 78,888 | 3,722 | 3,266 | 4,328 | N/A |
12/31/2020 | 77,155 | 3,367 | 4,675 | 5,639 | N/A |
9/30/2020 | 74,388 | 4,153 | 4,970 | 5,868 | N/A |
6/30/2020 | 70,554 | 3,502 | 5,637 | 6,495 | N/A |
3/31/2020 | 67,716 | 2,614 | 4,073 | 4,862 | N/A |
12/31/2019 | 64,888 | 2,707 | 4,548 | 5,284 | N/A |
9/30/2019 | 62,761 | 2,550 | 3,757 | 4,439 | N/A |
6/30/2019 | 60,726 | 2,505 | 306 | 942 | N/A |
3/31/2019 | 58,740 | 1,758 | -1,234 | -617 | N/A |
12/31/2018 | 56,912 | 1,683 | 1,561 | 2,173 | N/A |
9/30/2018 | 55,933 | 1,512 | -989 | -405 | N/A |
6/30/2018 | 55,009 | 1,367 | 2,950 | 3,513 | N/A |
3/31/2018 | 54,284 | 1,824 | 2,996 | 3,532 | N/A |
12/31/2017 | 53,767 | 2,448 | 3,527 | 4,051 | N/A |
9/30/2017 | 53,456 | 1,863 | N/A | 4,189 | N/A |
6/30/2017 | 53,868 | 1,814 | N/A | 5,829 | N/A |
3/31/2017 | 54,341 | 1,475 | N/A | 5,639 | N/A |
12/31/2016 | 54,379 | 614 | N/A | 1,936 | N/A |
9/30/2016 | 54,862 | 1,116 | N/A | 5,046 | N/A |
6/30/2016 | 54,531 | 980 | N/A | 1,575 | N/A |
3/31/2016 | 54,256 | 1,100 | N/A | 1,263 | N/A |
12/31/2015 | 54,289 | 1,276 | N/A | 868 | N/A |
9/30/2015 | 53,256 | 1,320 | N/A | 724 | N/A |
6/30/2015 | 52,131 | 1,296 | N/A | 646 | N/A |
3/31/2015 | 50,621 | 1,209 | N/A | 1,054 | N/A |
12/31/2014 | 48,500 | 1,147 | N/A | 1,618 | N/A |
9/30/2014 | 46,359 | 972 | N/A | 1,409 | N/A |
6/30/2014 | 44,440 | 1,050 | N/A | 1,602 | N/A |
3/31/2014 | 42,539 | 1,126 | N/A | 1,975 | N/A |
12/31/2013 | 41,313 | 1,231 | N/A | 1,716 | N/A |
9/30/2013 | 40,683 | 1,453 | N/A | 1,937 | N/A |
6/30/2013 | 40,015 | 1,511 | N/A | -544 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: HUMDas prognostizierte Gewinnwachstum (13.7% pro Jahr) liegt über der Sparquote (2.2%).
Ertrag vs. Markt: HUMDie Erträge des Unternehmens (13.7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.9% pro Jahr).
Hohe Wachstumserträge: HUMDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: HUMDie Einnahmen des Unternehmens (8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8% pro Jahr).
Hohe Wachstumseinnahmen: HUMDie Einnahmen des Unternehmens (8.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: HUMDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (16.7%).